Clinical Trial Delays and Trial Impact from COVID-19
A time-specific risk in which the spread of COVID-19 and lockdowns temporarily suspend clinical trials and other studies at medical institutions, delaying development progress.
Companies21How many companies write about this.
Threads21One company can carry more than one thread here.